KSKentaro Shimokado

Kentaro Shimokado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kentaro Shimokado has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Eiji Kaneko

    Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School, Tokyo, Japan

    2 shared publications
  • Tsuyoshi Chiba

    Geriatrics and Vascular Medicine, Tokyo Medical and Dental University Graduate School, Tokyo, Japan

    2 shared publications
  • E. Kaneko

    From the National Cardiovascular Center Research Institute (T.N., T.C., K.S.), Osaka; First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd. (T.N.), Tokushima; and Tokyo Medical and Dental University Graduate School (T.N., T.C., E.K., K.Y., M.Y., K.S.), Tokyo, Japan

    1 shared publication
  • K. Yui

    From the National Cardiovascular Center Research Institute (T.N., T.C., K.S.), Osaka; First Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd. (T.N.), Tokushima; and Tokyo Medical and Dental University Graduate School (T.N., T.C., E.K., K.Y., M.Y., K.S.), Tokyo, Japan

    1 shared publication
  • Katsumasa Yui

    From Tokyo Medical and Dental University Graduate School, Vascular Medicine and Geriatrics, Tokyo, Japan

    1 shared publication
  • Koichi Kokame

    Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Osaka, Japan

    1 shared publication

Latest Publications

  • Open Access

    A Deficiency of Herp, an Endoplasmic Reticulum Stress Protein, Suppresses Atherosclerosis in ApoE Knockout Mice by Attenuating Inflammatory Responses

    by Shohei Shinozaki, Tsuyoshi Chiba, Koichi Kokame, Toshiyuki Miyata, Eiji Kaneko, Kentaro Shimokado

    Herp was originally identified as an endoplasmic reticulum (ER) stress protein in vascular endothelial cells. ER stress is induced in atherosclerotic lesions, but it is not known whether Herp plays any role in the development of atherosclerosis. To address this question, we generated Herp- and apolipoprotein E (apoE)-deficient mice (Herp−/−; apoE−/− mice) by crossbreeding Herp−/− mice and apoE−/− mice. Herp was expressed in the endothelial cells and medial smooth muscle cells of the aorta, as well as in a subset of macrophages in the atherosclerotic lesions in apoE−/− mice, while there was no expression of Herp in the Herp−/−; apoE−/− mice. The doubly deficient mice developed significantly fewer atherosclerotic lesions than the apoE−/− mice at 36 and 72 weeks of age, whereas the plasma levels of cholesterol and triglycerides were not significantly different between the strains. The plasma levels of non-esterified fatty acids were significantly lower in the Herp−/−; apoE−/− mice when they were eight and 16 weeks old. The gene expression levels of ER stress response proteins (GRP78 and CHOP) and inflammatory cytokines (IL-1β, IL-6, TNF-α and MCP-1) in the aorta were significantly lower in Herp−/−; apoE−/− mice than in apoE−/− mice, suggesting that Herp mediated ER stress-induced inflammation. In fact, peritoneal macrophages isolated from Herp-deficient mice and RAW264.7 macrophages in which Herp was eliminated with a siRNA expressed lower levels of mRNA for inflammatory cytokines when they were treated with tunicamycin. Herp deficiency affected the major mediators of the unfolded protein response, including IRE1 and PERK, but not ATF6. These findings suggest that a deficiency of Herp suppressed the development of atherosclerosis by attenuating the ER stress-induced inflammatory reactions.


  • Insulin Signaling in Arteries Prevents Smooth Muscle Apoptosis

    by T. Nakazawa, T. Chiba, E. Kaneko, K. Yui, M. Yoshida, K. Shimokado

    Objective—Insulin is an antiapoptotic factor of cultured vascular cells, but it is not clear whether it also exerts antiapoptotic effects on vascular cells in vivo. We studied insulin receptor signaling in the arteries of normal and diabetic rats to establish whether insulin exhibits antiapoptotic activity toward vascular smooth muscle cells in vivo as well as in vitro.Methods and Results—Western blot analysis and real-time polymerase chain reaction revealed α- and β-subunits of the insulin receptor in association with insulin receptor substrate-1 and phosphatidylinositol 3-kinase in the media of the aorta and carotid artery. The insulin receptor signaling pathway was partially activated under physiological conditions, further activated by intravenous insulin injection, and was attenuated in streptozotocin-induced diabetic rats. Lipopolysaccharide injection induced more apoptosis of vascular smooth muscle cells in diabetic rats than in control rats, whereas insulin prevented apoptosis in the aortic wall. An in vitro study suggested that the antiapoptotic effect of insulin was mediated by phosphatidylinositol 3-kinase.Conclusions—Insulin is an antiapoptotic factor of vascular smooth muscle cells in vitro and in vivo. Decreased insulin activity on the artery may increase smooth muscle cell death and cause unstable plaque formation associated with diabetes.


  • VLDL Induces Adipocyte Differentiation in ApoE-Dependent Manner

    by Tsuyoshi Chiba, Toru Nakazawa, Katsumasa Yui, Eiji Kaneko, Kentaro Shimokado

    Objective—To clarify the role of very low density lipoprotein (VLDL) and apolipoprotein E (apoE) in adipogenesis, we studied newly developed hyperlipidemic obese (ob/ob;apoE−/−) mice. Because hydrolysis of VLDL is believed to be the major source of adipogenic free fatty acids, a higher plasma level of VLDL in these mice should exaggerate obesity.Methods and Results—When fed a high-fat, high-cholesterol diet,ob/ob;apoE−/−mice did not show increased body weight or an increased amount of adipose tissue in spite of increased plasma VLDL levels, whereasob/obmice showed an increased body weight and amount of adipose tissue, suggesting that there is a novel apoE-dependent pathway for adipogenesis. In vitro experiments using bone marrow stromal cells and 3T3-L1 cells confirmed this notion. ApoE-deficient VLDL did not induce adipogenesis, whereas normal VLDL induced adipogenesis in these cells. The incubation of apoE-deficient VLDL with recombinant human apoE restored its adipogenic activity. Tetrahydrolipstatin, a lipoprotein lipase inhibitor, did not affect the adipogenic activity of VLDL, suggesting that hydrolysis of VLDL did not play a major role in its effects. In fact, lipid components of VLDL or free fatty acids induced only partial adipogenesis.Conclusions—Our findings indicate that VLDL induces adipogenesis in an apoE-dependent manner both in vitro and in vivo.